(Q24811026)

4 July 2017

title

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease (English)

1 reference

4 July 2017

main subject

arterial hypertension

1 reference

chronic obstructive pulmonary disease

inferred from title

0 references

pulmonary hypertension

1 reference

1 reference

Nicholas W Morrell

1

0 references

author name string

Matthew A Higham

2

1 reference

4 July 2017

Peter G Phillips

3

1 reference

4 July 2017

B Haleema Shakur

4

1 reference

4 July 2017

Paul J Robinson

5

1 reference

4 July 2017

Ray J Beddoes

6

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

4 July 2017

1 reference

4 July 2017

volume

6

1 reference

4 July 2017

issue

1

0 references

page(s)

88

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

4 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Studies of pulmonary hypertension. I. Pulmonary circulatory dynamics in patients with pulmonary emphysema at rest

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

A pathophysiological study of 10 cases of hypoxic cor pulmonale

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Right ventricular angiotensin converting enzyme activity and expression is increased during hypoxic pulmonary hypertension.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Elevated pulmonary artery pressure. An independent predictor of mortality.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Effects of captopril combined with oxygen therapy at rest and on exercise in patients with chronic bronchitis and pulmonary hypertension.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Patterns of cardiovascular dysfunction in chronic obstructive lung disease.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1198258

Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-88

Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-88

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-88

Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-88

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-88

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-88

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

21 January 2018

1 reference

12 December 2020

Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation

1 reference

12 December 2020

Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension

1 reference

12 December 2020

Electrocardiographic signs of chronic cor pulmonale: A negative prognostic finding in chronic obstructive pulmonary disease

1 reference

12 December 2020

Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors

1 reference

12 December 2020

Transpulmonary angiotensin II formation and pulmonary haemodynamics in stable hypoxic lung disease: the effect of captopril

1 reference

12 December 2020

Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organ

1 reference

12 December 2020

Persistent hemodynamic and clinical improvement after captopril in patients with pulmonary hypertension

1 reference

12 December 2020

Captopril effects on pulmonary and systemic hemodynamics in chronic cor pulmonale

1 reference

12 December 2020

Failure of saralasin acetate, a competitive inhibitor of angiotensin II, to diminish alveolar hypoxic vasoconstriction in the dog

1 reference

12 December 2020

Pulmonary hypertension in congestive heart failure complicating chronic lung disease

1 reference

12 December 2020

Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD

1 reference

12 December 2020

Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-6-88

1 reference

Dimensions Publication ID

4 July 2017

0 references

1 reference

4 July 2017

1 reference